DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR CYPROHEPTADINE HYDROCHLORIDE

See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Cyproheptadine Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00066248	Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment	Completed	National Cancer Institute (NCI)	Phase 2	2003-06-01	RATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer. PURPOSE: This phase II trial is studying how well cyproheptadine and megestrol work in improving appetite and preventing weight loss in children with cachexia caused by cancer or cancer treatment.
NCT00066248	Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment	Completed	University of South Florida	Phase 2	2003-06-01	RATIONALE: Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer. PURPOSE: This phase II trial is studying how well cyproheptadine and megestrol work in improving appetite and preventing weight loss in children with cachexia caused by cancer or cancer treatment.
NCT00108420	Prazosin Treatment for Combat Trauma PTSD (Post-Traumatic Stress Disorder) Nightmares and Sleep Disturbance	Completed	VA Office of Research and Development	Phase 4	2003-10-01	The purpose of this study is to determine whether prazosin will reduce the incidence of nightmares, sleep disturbance, and overall symptoms in combat trauma-exposed individuals with PTSD.

Clinical Trial Conditions for Cyproheptadine Hydrochloride

Condition Name

Condition Name for Cyproheptadine Hydrochloride
Intervention	Trials
Leukemia	2
Myelodysplastic Syndromes	2
Epidermolysis Bullosa	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Cyproheptadine Hydrochloride
Intervention	Trials
Alcoholism	3
Epidermolysis Bullosa	2
Spinal Cord Injuries	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Cyproheptadine Hydrochloride

Trials by Country

Trials by Country for Cyproheptadine Hydrochloride
Location	Trials
United States	65
Brazil	2
Germany	2
Australia	2
Canada	2

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Cyproheptadine Hydrochloride
Location	Trials
California	5
Illinois	5
Texas	4
District of Columbia	3
Washington	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Cyproheptadine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Cyproheptadine Hydrochloride
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	5
Phase 2	7

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Cyproheptadine Hydrochloride
Clinical Trial Phase	Trials
Completed	9
Recruiting	3
Terminated	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Cyproheptadine Hydrochloride

Sponsor Name

Sponsor Name for Cyproheptadine Hydrochloride
Sponsor	Trials
National Cancer Institute (NCI)	3
Rehabilitation Institute of Chicago	3
University of South Florida	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Cyproheptadine Hydrochloride
Sponsor	Trials
Other	23
NIH	6
Industry	5

Export unavailable in trial.
Subscribe for complete access.